中商官网
研究报告
华润医药（HK3320）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 现金及现金等价物净增加额 |
-819071.10 | 941727.90 | 87582.90 | 665707.70 | -46283.70 | -386012.20 | 311340.60 | -52715.80 | 154112.90 | 51528.50 | -70205.40 | 232210.50 |
| 经营活动现金流量净额 |
1753551.00 | 1554989.00 | 1082114.00 | 1284250.00 | 820630.00 | 814093.90 | 824696.50 | 485753.80 | 411964.70 | 598878.90 | 418672.20 | 410215.70 |
| 投资活动现金流量净额 |
-888777.10 | -206728.70 | -81923.90 | -919080.10 | -225462.60 | 100879.20 | -980100.20 | -851156.70 | -195306.00 | -391922.20 | -797908.80 | -578872.10 |
| 融资活动现金流量净额 |
-1683845.00 | -406531.90 | -912607.00 | 300537.50 | -641451.10 | -1300985.00 | 466744.30 | 312687.10 | -62545.80 | -155428.30 | 309031.20 | 400866.90 |
| 现金及现金等价物期末余额 |
1642474.00 | 2465067.00 | 1522373.00 | 1752589.00 | 1123150.00 | 1254814.00 | 1663634.00 | 1417473.00 | 1397225.00 | 1321495.00 | 1373594.00 | 1517539.00 |
| 经营活动现金流量净额 |
1753551.00 | 1554989.00 | 1082114.00 | 1284250.00 | 820630.00 | 814093.90 | 824696.50 | 485753.80 | 411964.70 | 598878.90 | 418672.20 | 410215.70 |
| 折旧与摊销 |
335671.00 | 316436.50 | 255844.10 | 282189.00 | 244405.30 | 236484.70 | 161646.80 | 156570.50 | 127446.40 | 134584.70 | 135280.30 | 119569.70 |
| 营运资金变动 |
283347.60 | 160142.00 | -60191.70 | 30031.80 | -376249.70 | -201183.30 | -303725.10 | -512128.20 | -415813.90 | -221260.00 | -363888.90 | -369897.00 |
| 投资活动现金流量净额 |
-888777.10 | -206728.70 | -81923.90 | -919080.10 | -225462.60 | 100879.20 | -980100.20 | -851156.70 | -195306.00 | -391922.20 | -797908.80 | -578872.10 |
| 资本性支出 |
320282.70 | 313271.50 | 274006.20 | 314563.90 | 221849.90 | 204051.20 | 198668.90 | 201303.50 | 198231.60 | 243576.20 | 319181.00 | 299580.90 |
| 投资购买 |
-3446938.00 | -2406929.00 | -2634442.00 | -2828005.00 | -3575545.00 | -3562840.00 | -2105365.00 | -715042.20 | -1551301.00 | -1662604.00 | -1505835.00 | -432142.40 |
| 融资活动现金流量净额 |
-1683845.00 | -406531.90 | -912607.00 | 300537.50 | -641451.10 | -1300985.00 | 466744.30 | 312687.10 | -62545.80 | -155428.30 | 309031.20 | 400866.90 |
| 股份回购 |
-7587.20 | -- | -41417.00 | -8676.10 | -14543.50 | -16284.70 | -- | -- | -- | -- | -- | -- |
| 支付股息 |
-555050.40 | -322522.20 | -270600.10 | -188646.80 | -148924.30 | -200123.50 | -401057.10 | -190316.50 | -215898.70 | -95151.20 | -108823.20 | -88667.00 |
| 股票发行 |
-- | -- | -- | -- | -- | -- | -- | -- | 1506125.00 | -- | -- | 528201.40 |
| 现金及现金等价物净增加额 |
-819071.10 | 941727.90 | 87582.90 | 665707.70 | -46283.70 | -386012.20 | 311340.60 | -52715.80 | 154112.90 | 51528.50 | -70205.40 | 232210.50 |
| 加：现金及现金等价物期初余额 |
2465067.00 | 1522373.00 | 1431597.00 | 1123150.00 | 1254814.00 | 1663634.00 | 1417473.00 | 1397225.00 | 1321495.00 | 1373594.00 | 1517539.00 | 1269363.00 |
| 汇率变动对现金及现金等价物的影响 |
-3522.00 | 966.40 | 3192.40 | -36268.90 | -85380.70 | -22807.40 | -65180.30 | 72964.00 | -78382.30 | -103628.30 | -73738.90 | 15965.70 |
| 现金及现金等价物期末余额 |
1642474.00 | 2465067.00 | 1522373.00 | 1752589.00 | 1123150.00 | 1254814.00 | 1663634.00 | 1417473.00 | 1397225.00 | 1321495.00 | 1373594.00 | 1517539.00 |